Kyle Humphries

Head of Product & Technology @Tally Health

New York, NY, US

Built & Scaled Tally Health’s Business, Driving AI-Powered Longevity Outcomes & Revenue Growth• Designed and executed Tally Health’s business model, owning product commercialization and revenue growth from pre-launch through present.• Scaled from zero revenue at launch (2023) to multi-millions in 2024, by optimizing product-market fit, scaling digital subscriptions, and leading commercialization strategy.• Led the launch and evolution of TallyAge™, an AI-powered epigenetic age test trained on the largest buccal tissue methylation dataset, delivering relevant biological age insights.• Worked across all business functions—engineering, bioinformatics, marketing, operations, and partnerships—to prioritize and commercialize AI/ML-driven product enhancements, improving accuracy and customer engagement.• Drove measurable longevity improvements, helping customers reduce their epigenetic age by an average of 2+ years within 12 months, via recurring healthspan measurement and personalized interventions.• Secured strategic partnerships with OneSkin & Pvolve, establishing TallyAge as the premium standard in longevity testing, backed by AI/ML technology and David Sinclair’s endorsement.• Influenced investor strategy and secured funding, aligning board priorities with AI-driven product expansion and D2C longevity solutions.Tally Health was founded by L Catterton and Dr. David Sinclair, a Harvard professor and global leader in aging and epigenetics.

Lazaridis School of Business & Economics at Wilfrid Laurier University

Bachelor’s Degree